Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardiff Oncology (CRDF) Gross Profit (2016 - 2019)

Historic Gross Profit for Cardiff Oncology (CRDF) over the last 7 years, with Q4 2019 value amounting to $92577.0.

  • Cardiff Oncology's Gross Profit rose 1866.56% to $92577.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $244633.0, marking a year-over-year increase of 21163.73%. This contributed to the annual value of $244632.0 for FY2019, which is 21163.68% up from last year.
  • According to the latest figures from Q4 2019, Cardiff Oncology's Gross Profit is $92577.0, which was up 1866.56% from $51687.0 recorded in Q3 2019.
  • In the past 5 years, Cardiff Oncology's Gross Profit registered a high of $92577.0 during Q4 2019, and its lowest value of -$3.0 million during Q2 2016.
  • Its 5-year average for Gross Profit is -$927663.4, with a median of -$308040.5 in 2017.
  • As far as peak fluctuations go, Cardiff Oncology's Gross Profit tumbled by 33998.18% in 2016, and later skyrocketed by 14140.22% in 2019.
  • Quarter analysis of 5 years shows Cardiff Oncology's Gross Profit stood at -$1.9 million in 2015, then fell by 25.43% to -$2.3 million in 2016, then surged by 91.47% to -$198593.0 in 2017, then skyrocketed by 139.28% to $78015.0 in 2018, then increased by 18.67% to $92577.0 in 2019.
  • Its Gross Profit stands at $92577.0 for Q4 2019, versus $51687.0 for Q3 2019 and $38348.0 for Q2 2019.